Conference Coverage: SABCS 2022
Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.
FACULTY CHAIR
Adam Brufsky, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA
Faculty Members
Mark Pegram, MD
Stanford Cancer Institute, Stanford, CA, USA
Mary Cianfrocca, DO, MBA
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA
Priyanka Sharma, MD
University of Kansas Medical Center, Kansas City, KS, USA
Peter Beitsch, MD
Dallas Surgical Group, Dallas, TX, USA
Pat Whitworth, MD, FACS, FSSO
Nashville Breast Center, Nashville, TN, USA
Peter Kaufman, MD
University of Vermont Cancer Center, Burlington, VT, USA
Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain
Guy Jerusalem, MD, PhD
Centre Hospitalier Universitaire, Liège, Belgium
Giuseppe Curigliano, MD, PhD
Istituto Europeo di Oncologia, Milan, Italy
REPORT TOPICS INCLUDE
- Advancing Therapy for Metastatic HER2+ Breast Cancer
- Other Novel Endocrine Strategies for ER+ Breast Cancer
- ER+ Breast Cancer – Targeting CDKs
- Targeting Triple-Negative Breast Cancer
- Biomarkers and Tailored Therapy
- Other Novel Therapeutic Approaches for Breast Cancer
